Eastern Cooperative Oncology Group (ECOG) Performance Status

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
ecog score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • ECOG 00–0
  • ECOG 11–1
  • ECOG 22–2
  • ECOG 33–3
Direct Clinical Answer

The Eastern Cooperative Oncology Group (ECOG) Performance Status calculates staging malignant disease, estimating overall survival, and assessing chemotherapy tolerability. Key inputs include performance status. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Determines patient's ability to tolerate therapies in severe illness, specifically for chemotherapy. Simple 5-point scale that describes patient's level of functioning in terms of their ability to care for themselves, daily activity, and physical ability.

Clinical Indication

The Eastern Cooperative Oncology Group (ECOG) Performance Status is indicated for bedside clinical practice to support Determines patient's ability to tolerate therapies in severe illness, specifically for chemotherapy. Simple 5-point scale that describes patient's level of functioning in terms of their ability to care for themselves, daily activity, and physical ability.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.

Limitations & Contraindications

Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.

Clinical Pearls & Action Plan

Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival. Guideline pearl: Widely used for determining eligibility for clinical trials and treatment decisions..

Formula & Variables:

Direct assessment scale with 5 defined levels (0-4) based on patient's functional status and ability to perform activities of daily living. No mathematical calculation required - clinician selects appropriate level based on patient assessment.

Input Parameters

NameTypeRequiredDescription
performance_statusstringYesPatient's current performance status based on functional assessment

Score Interpretation & Guidance

RangeStageDescription
0–0ECOG 0Fully active
1–1ECOG 1Restricted in strenuous activity
2–2ECOG 2Ambulatory but unable to work
3–3ECOG 3Limited self-care
4–4ECOG 4Completely disabled

Evidence-Based References (EBM)

  • Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649-55. doi: 10.1097/00000421-198212000-00014.DOI: 10.1097/00000421-198212000-00014
  • Zubrod CG, Schneiderman M, Frei E, Brindley C, Gold GL, Shnider B, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis. 1960;11:7-33. doi: 10.1016/0021-9681(60)90137-5.DOI: 10.1016/0021-9681(60)90137-5
  • Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer. 1996;32A(7):1135-41. doi: 10.1016/0959-8049(95)00664-8.DOI: 10.1016/0959-8049(95)00664-8
  • Ma C, Bandukwala S, Burman D, Bryson J, Seccareccia D, Banerjee S, et al. Interconversion of three measures of performance status: an empirical analysis. Eur J Cancer. 2010;46(18):3175-83. doi: 10.1016/j.ejca.2010.06.126.DOI: 10.1016/j.ejca.2010.06.126

Related calculators